Everything we know about the human body comes from studying whole body donors. At MedCure, we connect you or your loved ones to the physicians, surgeons, and researchers who are continuing this vital work. Their discoveries and innovations help people live longer, make treatments less invasive, and create new ways to prevent illness or disease.
We are constantly overwhelmed by the incredible generosity and selflessness of our donors. MedCure honors their gifts by covering, upon acceptance, all expenses related to the donation process. These costs include transportation from the place of passing, cremation, and a certified copy of the death certificate, as well as the return of cremated remains to the family or a scattering of the ashes at sea.
By request, we can provide a family letter that shares more detailed information on how you or your loved one contributed to medical science. Donation Coordinators are available 24 hours a day to answer your questions and assist you with the donation process. Whether you are registering your future intent to be a body donor, you are currently receiving hospice care, or if your loved one has already passed, we can guide you through every step.
We are available 24 hours a day to conduct a donor eligibility screening or to verify a donor pre-registration is on file. MedCure makes all of the transportation arrangements from the place of passing to one of our five US facilities at no cost to the donor or their caregivers.
Donors are matched to institutions or projects according to medical history and current research needs. Family letters provide details on request. Cremated remains are returned to the family within 8 - 12 weeks or may be scattered at sea. A certified death certificate is provided to the family or estate. I was brought into this world via medical science and it is my choice to leave that way. MedCure and their representatives handled both my parents in the most kind and professional manner.
They made me feel comfortable with my decisions and had such compassion for all my thoughts and questions. MedCure offers a pre-screening program for patients who are receiving hospice care or who have been given a life expectency of 6 months or less. You can download our Hospice Patient Registry Kit to help guide you through each step of the process. A donor's legal next of kin or Healthcare Power of Attorney can legally assist in arranging for body donation. A full and complete copy of the Healthcare Power of Attorney documents must be submitted with the body donation forms.
A Donation Coordinator will ask screening questions to determine if an individual meets certain medical research criteria necessary for body donation. Donation forms are available HERE. Completed documentation can be emailed to donate medcure. MedCure should be called immediately to determine or review the donor's eligibility screening and to begin making transportation arrangements. If you or your loved one is close to passing, or if your loved one has just passed, please bypass pre-registry and phone MedCure right away.
If you would like to register your intent to donate your body to science, please complete the pre-registry form and click the SEND button. After you register, we will mail you a welcome kit with additional information within two to three weeks.
This kit explains the body donation process and includes a donor card for your wallet. Purpose: To compare the outcomes of patients with Hodgkin or non-Hodgkin lymphoma undergoing nonmyeloablative haploidentical or unrelated cord blood UCB hematopoietic cell transplantation.
All patients received a uniform transplantation conditioning regimen 2 Gy of total-body irradiation, cyclophosphamide, and fludarabine and graft-versus-host disease prophylaxis calcineurin inhibitor and mycophenolate. In addition, patients who received a haploidentical transplantation received posttransplantation cyclophosphamide. Results: Compared with haploidentical bone marrow and peripheral-blood transplantations and adjusted for age, lymphoma subtype, and disease status, survival was lower after UCB transplantation hazard ratio [HR], 1.
Similarly, progression-free survival was lower after UCB transplantations compared with haploidentical bone marrow and peripheral-blood transplantations HR, 1. Lower survival was attributed to higher transplantation-related mortality after UCB transplantation compared with haploidentical bone marrow and peripheral-blood transplantation HR, 1.
0コメント